"Polsko-Amerykańskich Klinik Serca Centrum Sercowo-Naczyniowe w Chrzanowie to jeden z pierwszych ośrodków w Polsce, w obrębie którego umieszczono oddział kardiologii inwazyjnej, chirurgii naczyniowej oraz pracownię rezonansu magnetycznego. Pozwala to na szeroko pojętą kompleksową ocenę pacjenta pod kątem występowania chorób serca i naczyń. Takie rozwiązanie jest szczególnie korzystne dla chorego dotkniętego miażdżycą, która zazwyczaj nie ogranicza się do jednego obszaru naczyniowego. Zabiegi ratujące ludzkie życie są wykonywane w klinice przez całą dobę (dyżury 24h). Polsko-Amerykańskie Kliniki Serca Centrum Sercowo-Naczyniowe w Chrzanowie otrzymało certyfikat akredytacyjny według tzw. nowych standardów jako drugi szpital w Polsce."

During the past decade, Malopolskie Centrum Sercowo-Naczyniowe conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Malopolskie Centrum Sercowo-Naczyniowe" #1 collaborator was "ICON plc" with 1 trials as a collaborator, "Medidata Solutions" with 1 trials as a collaborator and "PPD" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Malopolskie Centrum Sercowo-Naczyniowe" are "Coronary Artery Disease" (1 trials), "Diabetes Mellitus, Type 2" (1 trials) and "ST Elevation Myocardial Infarction" (1 trials). Many other conditions were trialed in "Malopolskie Centrum Sercowo-Naczyniowe" in a lesser frequency.

Most popular intervention types in "Malopolskie Centrum Sercowo-Naczyniowe" are "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "(BMS/DES)" (1 trials), "Apabetalone" (1 trials), "Atorvastatin" (1 trials), "MGuard Prime" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Malopolskie Centrum Sercowo-Naczyniowe" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Malopolskie Centrum Sercowo-Naczyniowe". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Malopolskie Centrum Sercowo-Naczyniowe, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Malopolskie Centrum Sercowo-Naczyniowe, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".